SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001171843-19-005217
Filing Date
2019-08-07
Accepted
2019-08-06 18:00:11
Documents
7

Document Format Files

Seq Description Document Type Size
1 FORM F-3 f3_080619.htm F-3 272156
2 EXHIBIT 4.6 exh_46.htm EX-4.6 75044
3 EXHIBIT 5.1 exh_51.htm EX-5.1 12817
4 EXHIBIT 23.1 exh_231.htm EX-23.1 6328
5 GRAPHIC logo.jpg GRAPHIC 12677
6 GRAPHIC kpmg.jpg GRAPHIC 10175
7 GRAPHIC osler.jpg GRAPHIC 9569
  Complete submission text file 0001171843-19-005217.txt   396129
Mailing Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3
Business Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3 450-686-4555
Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0331
Type: F-3 | Act: 33 | File No.: 333-233063 | Film No.: 191003333
SIC: 2834 Pharmaceutical Preparations